Mechanisms underlying epilepsies associated with sodium channel mutations

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 97-111

  Steinlein, Ortrud K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dravet syndrome; Epilepsy; GEFS+; SCN1A; Voltage gated sodium channels

Indexed keywords

VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ARTICLE; CONVULSION; EPILEPSY; FEBRILE CONVULSION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; GENETIC ASSOCIATION; GENETICS; GENOTYPE; MUTATION;

EPILEPSY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MUTATION; PHENOTYPE; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84926386808     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00005-3     Document Type: Chapter

References (89)

1. Alabi A.A., Bahamonde M.I., Jung H.J., Kim J.I., Swartz K.J. Portability of paddle motif function and pharmacology in voltage sensors. Nature 2007, 450:370-375.
2. Auerbach D., Shi H.L., Liu Y., Jones J.M., Meisler M.H., Isom L.L., Parent J.M. Dravet syndrome patient-derived cells and mouse model suggest SUDEP mechanisms. Ann. Neurol. 2012, 72:S58.
3. Baulac S., Gourfinkel-An I., Picard F., Rosenberg-Bourgin M., Prud'homme J.F., Baulac M., Brice A., LeGuern E. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am. J. Hum. Genet. 1999, 65:1078-1085.
4. Berkovic S.F., Heron S.E., Giordano L., Marini C., Guerrini R., Kaplan R.E., Gambardella A., Steinlein O.K., Grinton B.E., Dean J.T., Bordo L., Hodgson B.L., Yamamoto T., Mulley J.C., Zara F., Scheffer I.E. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann. Neurol. 2004, 55:550-557.
5. Bosmans F., Martin-Eauclaire M.F., Swartz K.J. Deconstructing voltage sensor function and pharmacology in sodium channels. Nature 2008, 456:202-208.
6. Carranza Rojo D., Hamiwka L., McMahon J.M., Dibbens L.M., Arsov T., Suls A., Stodberg T., Kelley K., Wirrell E., Appleton B., Mackay M., Freeman J.L., Yendle S.C., Berkovic S.F., Bienvenu T., De Jonghe P., Thorburn D.R., Mulley J.C., Mefford H.C., Scheffer I.E. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology 2011, 77:380-383.
7. Catterall W.A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000, 26:13-25.
8. Catterall W.A., Goldin A.L., Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57:397-409.
9. Catterall W.A., Kalume F., Oakley J.C. Na(V)1.1 channels and epilepsy. J. Physiol. Lond. 2010, 588:1849-1859.
10. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 2001, 68:1327-1332.
11. Depienne C., Trouillard O., Gourfinkel-An I., Saint-Martin C., Bouteiller D., Graber D., Barthez-Carpentier M.A., Gautier A., Villeneuve N., Dravet C., Livet M.O., Rivier-Ringenbach C., Adam C., Dupont S., Baulac S., Heron D., Nabbout R., LeGuern E. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J. Med. Genet. 2010, 47:404-410.
12. Doose H., Lunau H., Castiglione E., Waltz S. Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 1998, 29:229-238.
13. Doty C.N. SCN9A: another sodium channel excited to play a role in human epilepsies. Clin. Genet. 2010, 77(4):326-328.
14. Duflocq A., Le Bras B., Bullier E., Couraud F., Davenne M. Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol. Cell. Neurosci. 2008, 39:180-192.
15. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., Brice A., LeGuern E., Moulard B., Chaigne D., Buresi C., Malafosse A. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 2000, 24:343-345.
16. Estacion M., Gasser A., Dib-Hajj S.D., Waxman S.G. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons. Exp. Neurol. 2010, 224:362-368.
17. Faisal A.A. Studying channelopathies at the functional level using a system identification approach. AIP. Conf. Proc. 2007, 940:113-126.
18. Fozzard H.A., Hanck D.A. Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol. Rev. 1996, 76:887-926.
19. Fujiwara T., Sugawara T., Mazaki-Miyazaki E., Takahashi Y., Fukushima K., Watanabe M., Hara K., Morikawa T., Yagi K., Yamakawa K., Inoue Y. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 2003, 126:531-546.
20. Fukuma G., Oguni H., Shirasaka T., Watanabe K., Miyajima T., Yasumoto S., Ohfu M., Inoue T., Watanachai A., Kira R., Matsuo M., Muranaka T., Sofue F., Zhang B., Kaneko S., Mitsudome A., Hirose S. Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia 2004, 45:140-148.
21. Genmaro E., Santorelli F.M., Bertini E., Buti D., Gaggero R., Gobbi G., Lini M., Granata T., Freri E., Parmeggiani A., Striano P., Veggiotti P., Cardinali S., Bricarelli F.D., Minetti C., Zara F. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem. Biophys. Res. Commun. 2006, 341:489-493.
22. Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., Kallen R.G., Mandel G., Meisler M.H., Netter Y.B., Noda M., Tamkun M.M., Waxman S.G., Wood J.N., Catterall W.A. Nomenclature of voltage-gated sodium channels. Neuron 2000, 28:365-368.
23. Gong B., Rhodes K.J., Bekele-Arcuri Z., Trimmer J.S. Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J. Comp. Neurol. 1999, 412:342-352.
24. Harkin L.A., McMahon J.M., Iona X., Dibbens L., Pelekanos J.T., Zuberi S.M., Sadleir L.G., Andermann E., Gill D., Farrell K., Connolly M., Stanley T., Harbord M., Andermann F., Wang J., Batish S.D., Jones J.G., Seltzer W.K., Gardner A., Sutherland G., Berkovic S.F., Mulley J.C., Scheffer I.E. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007, 130:843-852.
25. Heron S.E., Scheffer I.E., Iona X., Zuberi S.M., Birch R., McMahon J.M., Bruce C.M., Berkovic S.F., Mulley J.C. De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin. J. Med. Genet. 2010, 47:137-141.
26. Hu W., Tian C., Li T., Yang M., Hou H., Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat. Neurosci. 2009, 12:996-1002.
27. Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., Feldman O., Gepstein A., Arbel G., Hammerman H., Boulos M., Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471:225-229.
28. Jansen F.E., Sadleir L.G., Harkin L.A., Vadlamudi L., McMahon J.M., Mulley J.C., Scheffer I.E., Berkovic S.F. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006, 67:2224-2226.
29. Jia J., Yao P., Arif A., Fox P.L. Regulation and dysregulation of 3' UTR-mediated translational control. Curr. Opin. Genet. Dev. 2013, 23:29-34.
30. Kanai K., Hirose S., Oguni H., Fukuma G., Shirasaka Y., Miyajima T., Wada K., Iwasa H., Yasumoto S., Matsuo M., Ito M., Mitsudome A., Kaneko S. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 2004, 63:329-334.
31. Kaplan R.E., Lacey D.J. Benign familial neonatal-infantile seizures. Am. J. Med. Genet. 1983, 16(4):595-599.
32. Kearney J.A., Plummer N.W., Smith M.R., Kapur J., Cummins T.R., Waxman S.G., Goldin A.L., Meisler M.H. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001, 102:307-317.
33. Kimura K., Sugawara T., Mazaki-Miyazaki E., Hoshino K., Nomura Y., Tateno A., Hachimori K., Yamakawa K., Segawa M. A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures. Brain Dev. 2005, 27:424-430.
34. Kobow K., El-Osta A., Blumcke I. The methylation hypothesis of pharmacoresistance in epilepsy. Epilepsia 2013, 54:41-47.
35. Lewis T.B., Shevell M.I., Andermann E., Ryan S.G., Leach R.J. Evidence of a third locus for benign familial convulsions. J. Child Neurol. 1996, 11:211-214.
36. Livingston J.H., Cross J.H., Mclellan A., Birch R., Zuberi S.A. A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus. J. Child Neurol. 2009, 24:503-508.
37. Lorincz A., Nusser Z. Molecular identity of dendritic voltage-gated sodium channels. Science 2010, 328:906-909.
38. Malacarne M., Gennaro E., Madia F., Pozzi S., Vacca D., Barone B., Malacarne M., Gennaro E., Madia F., Pozzi S., Vacca D., Barone B., Dalla Bernardina B., Bianchi A., Bonanni P., De Marco P., Gambardella A., Giordano L., Lispi M.L., Romeo A., Santorum E., Vanadia F., Vecchi M., Veggiotti P., Vigevano F., Viri F., Bricarelli F.D., Zara F. Benign familial infantile convulsions: mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity. Am. J. Hum. Genet. 2001, 68:1521-1526.
39. Mantegazza M., Rusconi R., Scalmani P., Avanzini G., Franceschetti S. Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again. Epilepsy Res. 2010, 92(1):1-29.
40. Marini C., Mei D., Cross J.H., Guerrini R. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 2006, 47:1737-1740.
41. Marini C., Scheffer I.E., Nabbout R., Suls A., De Jonghe P., Zara F., Guerrini R. The genetics of Dravet syndrome. Epilepsia 2011, 52(Suppl. 2):24-29.
42. Martin M.S., Tang B., Papale L.A., Yu F.H., Catterall W.A., Escayg A. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum. Mol. Genet. 2007, 16:2892-2899.
43. Martin M.S., Dutt K., Papale L.A., Dube C.M., Dutton S.B., de Haan G., Shankar A., Tufik S., Meisler M.H., Baram T.Z., Goldin A.L., Escayg A. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J. Biol. Chem. 2010, 285:9823-9834.
44. Meisler M.H., Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest. 2005, 115:2010-2017.
45. Meisler M.H., O'Brien J.E., Sharkey L.M. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J. Physiol. Lond. 2010, 588:1841-1848.
46. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., Dorn T., Goedel A., Hohnke C., Hofmann F., Seyfarth M., Sinnecker D., Schomig A., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010, 363(15):1397-1409.
47. Morimoto M., Mazaki E., Nishimura A., Chiyonobu T., Sawai Y., Murakami A., Nakamura K., Inoue I., Ogiwara I., Sugimoto T., Yamakawa K. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 2006, 47:1732-1736.
48. Mulley J.C., Scheffer I.E., Petrou S., Dibbens L.A., Berkovic S.F., Harkin L.A. SCN1A mutations and epilepsy. Hum. Mutat. 2005, 25:535-542.
49. Mulley J.C., Nelson P., Guerrero S., Dibbens L., Iona X., McMahon J.M., Harkin L., Schouten J., Yu S., Berkovic S.F., Scheffer I.E. A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 2006, 67:1094-1095.
50. Nabbout R., Gennaro E., Dalla Bernardina B., Dulac O., Madia F., Bertini E., Capovilla G., Chiron C., Cristofori G., Elia M., Fontana E., Gaggero R., Granata T., Guerrini R., Loi M., La Selva L., Lispi M.L., Matricardi A., Romeo A., Tzolas V., Valseriati D., Veggiotti P., Vigevano F., Vallee L., Bricarelli F.D., Bianchi A., Zara F. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 2003, 60:1961-1967.
51. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., Yamakawa K. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 2007, 27(22):5903-5914.
52. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., Yamakawa K. Nav1.1 predominantly localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in Nav1.1-deficient mice. Neurosci. Res. 2007, 58:S40.
53. Ogiwara I., Ito K., Sawaishi Y., Osaka H., Mazaki E., Inoue I., Montal M., Hashikawa T., Shike T., Fujiwara T., Inoue Y., Kaneda M., Yamakawa K. De novo mutations of voltage-gated sodium channel alpha(II) gene SCN2A in intractable epilepsies. Neurology 2009, 73(13):1046-1053.
54. Ohmori I., Ohtsukaa Y., Ouchida M., Ogino T., Maniwa S., Shimizu K., Oka E. Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations?. Brain Dev. 2003, 25(7):488-493.
55. Oliva M., Berkovic S.F., Petrou S. Sodium channels and the neurobiology of epilepsy. Epilepsia 2012, 53(11):1849-1859.
56. Papale L.A., Beyer B., Jones J.M., Sharkey L.M., Tufik S., Epstein M., Letts V.A., Meisler M.H., Frankel W.N., Escayg A. Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice. Hum. Mol. Genet. 2009, 18(9):1633-1641.
57. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134(5):877-886.
58. Patino G.A., Claes L.R.F., Lopez-Santiago L.F., Slat E.A., Dondeti R.S.R., Chen C.L., O'Malley H.A., Gray C.B.B., Miyazaki H., Nukina N., Oyama F., De Jonghe P., Isom L.L. A functional null mutation of SCN1B in a patient with Dravet syndrome. J. Neurosci. 2009, 29(34):10764-10778.
59. Payandeh J., Gamal El-Din T.M., Scheuer T., Zheng N., Catterall W.A. Crystal structure of a voltage-gated sodium channel in two potentially inactivated states. Nature 2012, 486(7401):135-139.
60. Ragsdale D.S. How do mutant Nav1.1 sodium channels cause epilepsy?. Brain Res. Rev. 2008, 58(1):149-159.
61. Reid C.A., Berkovic S.F., Petrou S. Mechanisms of human inherited epilepsies. Prog. Neurobiol. 2009, 87(1):41-57.
62. Sato C., Ueno Y., Asai K., Takahashi K., Sato M., Engel A., Fujiyoshi Y. The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature 2001, 409(6823):1047-1051.
63. Sauna Z.E., Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 2011, 12(10):683-691.
64. Scheffer I.E. Severe infantile epilepsies: molecular genetics challenge clinical classification. Brain 2003, 126:513-514.
65. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120(Pt. 3):479-490.
66. Scheffer I.E., Zhang Y.H., Jansen F.E., Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?. Brain Dev. 2009, 31(5):394-400.
67. Selmer K.K., Eriksson A.S., Brandal K., Egeland T., Tallaksen C., Undlien D.E. Parental SCN1A mutation mosaicism in familial Dravet syndrome. Clin. Genet. 2009, 76(4):398-403.
68. Shevell M.I., Sinclair D.B., Metrakos K. Benign familial neonatal seizures: clinical and electroencephalographic characteristics. Pediatr. Neurol. 1986, 2(5):272-275.
69. Singh R., Andermann E., Whitehouse W.P.A., Harvey A.S., Keene D.L., Seni M.H., Crossland K.M., Andermann F., Berkovic S.F., Scheffer I.E. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS(+)?. Epilepsia 2001, 42(7):837-844.
70. Singh N.A., Pappas C., Dahle E.J., Claes L.R.F., Pruess T.H., De Jonghe P., Thompson J., Dixon M., Gurnett C., Peiffer A., White H.S., Filloux F., Leppert M.F. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet. 2009, 5(9):e1000649.
71. Somers J., Poyry T., Willis A.E. A perspective on mammalian upstream open reading frame function. Int. J. Biochem. Cell Biol. 2013, 45(8):1690-1700.
72. Stuhmer W., Conti F., Suzuki H., Wang X.D., Noda M., Yahagi N., Kubo H., Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature 1989, 339(6226):597-603.
73. Sugama M., Oguni H., Fukuyama Y. Clinical and electroencephalographic study of severe myoclonic epilepsy in infancy (Dravet). Jpn. J. Psychiatr. Neural. 1987, 41(3):463-465.
74. Sugawara T., Mazaki-Miyazaki E., Fukushima K., Shimomura J., Fujiwara T., Hamano S., Inoue Y., Yamakawa K. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002, 58(7):1122-1124.
75. Suls A., Claeys K.G., Goossens D., Harding B., Van Luijk R., Scheers S., Deprez L., Audenaert D., Van Dyck T., Beeckmans S., Smouts I., Ceulemans B., Lagae L., Buyse G., Barisic N., Misson J.P., Wauters J., Del-Favero J., De Jonghe P., Claes L.R.E. Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients. Hum. Mutat. 2006, 27(9):914-920.
76. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
77. Tang B., Dutt K., Papale L., Rusconi R., Shankar A., Hunter J., Tufik S., Yu F.H., Catterall W.A., Mantegazza M., Goldin A.L., Escayg A. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS plus) mutation. Neurobiol. Dis. 2009, 35(1):91-102.
78. Vassilev P.M., Scheuer T., Catterall W.A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science 1988, 241(4873):1658-1661.
79. Vassilev P., Scheuer T., Catterall W.A. Inhibition of inactivation of single sodium channels by a site-directed antibody. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(20):8147-8151.
80. Veeramah K.R., O'Brien J.E., Meisler M.H., Cheng X.Y., Dib-Hajj S.D., Waxman S.G., Talwar D., Girirajan S., Eichler E.E., Restifo L.L., Erickson R.P., Hammer M.F. De Novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am. J. Hum. Genet. 2012, 90(3):502-510.
81. +-channel beta 1 subunit gene SCN1B. Nat. Genet. 1998, 19(4):366-370.
82. Ward L.D., Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat. Biotechnol. 2012, 30(11):1095-1106.
83. West J.W., Patton D.E., Scheuer T., Wang Y., Goldin A.L., Catterall W.A. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(22):10910-10914.
84. + channel subtypes in central neurons. Neuron 1989, 3(6):695-704.
85. Whitaker W.R., Faull R.L., Waldvogel H.J., Plumpton C.J., Emson P.C., Clare J.J. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res. Mol. Brain Res. 2001, 88(1-2):37-53.
86. Yazawa M., Hsueh B., Jia X.L., Pasca A.M., Bernstein J.A., Hallmayer J., Dolmetsch R.E. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011, 471(7337):230-234.
87. Yu F.H., Catterall W.A. Overview of the voltage-gated sodium channel family. Genome Biol. 2003, 4(3):207.
88. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., Catterall W.A. Reduced sodium current in gabaergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 2006, 9(9):1142-1149.
89. Yu J.Y., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858):1917-1920.